Related coverage linked through entity extraction aliases.
Jul 31, 2026
Penn joined 35 universities in an amicus brief supporting Harvard’s lawsuit against a $2 billion federal research funding freeze. The brief warns that such cuts endanger basic research and innovation, as Penn itself faces over $400 million in recent funding freezes and cuts.
Jul 24, 2026
Two new studies clarify how Epstein-Barr virus may trigger multiple sclerosis: one shows a doubled CD4+ T cell response in untreated patients, while another reveals EBV-activated B cells cause brain inflammation in mice. Insights point to potential therapies targeting EBV-specific immune activity.
Jun 19, 2026
Portal Biotechnologies closes $9M funding round to expand cell engineering platform for drug discovery and cell therapy. Navikenz raises $7.5M seed round to scale AI transformation services focused on life sciences and pharmaceuticals.
Apr 26, 2026
Congress rejected the administration’s deepest proposed science cuts, increasing NIH funding by about $415 million to $48.7 billion. NASA and NSF also saw far smaller reductions than proposed.
Mar 21, 2026
The FDA has issued draft guidance creating a "Plausible Mechanism Framework" to accelerate approval of individualized therapies for ultra-rare diseases where traditional clinical trials are not feasible. The guidance focuses on gene editing and RNA-based treatments targeting specific genetic abnormalities.
Mar 14, 2026
Thousands of research positions have been terminated or frozen at federal agencies following deep cuts to U.S. science funding by the Trump administration, affecting work from aging studies to global food security.
Mar 13, 2026
The World Health Organization published blueprints for urgently needed antibiotics targeting drug-resistant infections, while CARB-X awarded $1.2 million for novel antibiotic research and the FDA issued guidance on antibiotic duration limits in livestock.
Mar 01, 2026
Artificial intelligence is revolutionizing rare disease diagnosis, cutting diagnostic timelines from years to weeks. Rare Disease Day on February 28 highlights challenges faced by over 300 million people worldwide living with more than 7,000 distinct rare conditions.
Feb 21, 2026
The controversy over direct-to-consumer prescription drug advertising has gained renewed attention from the Trump administration and legislators, with spending reaching $9 billion in 2024 and debate centering on whether such ads benefit or harm consumers.
Feb 26, 2026
Researchers at Stanford and Harvard are developing nasal spray vaccines offering broad protection against respiratory infections, with early animal and phase 1 human trials showing safety and potential efficacy.
Feb 19, 2026
Zsofia K. Stadler, MD, has been appointed as the next Editor-in-Chief of JCO Precision Oncology, effective July 1, 2026. She is an Attending Physician and Clinic Director at Memorial Sloan Kettering Cancer Center.
Feb 18, 2026
Researchers have identified how the MYC protein helps pancreatic cancer evade immune detection, while a separate team discovered methods to permanently switch off cancer genes in leukemia through epigenetic therapy targeting Menin and DOT1L proteins.
Feb 10, 2026
U.S. Health Secretary Robert F. Kennedy Jr. claimed ketogenic diets can cure schizophrenia, but psychiatry experts say the assertion goes far beyond what current scientific evidence supports.
